Cognex Corp. 10-K Summary: Fiscal Year Ended December 31, 2002
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2002. Cognex Corporation designs, develops, manufactures, and markets machine vision systems used to automate manufacturing processes. The company operates through two divisions: the Modular Vision Systems Division (MVSD), which accounted for 79% of 2002 revenue, and the Surface Inspection Systems Division (SISD). The company serves Original Equipment Manufacturers (OEMs) and end-users across semiconductor, electronics, automotive, and packaging industries.
Key Financial Metrics
Note: Specific revenue, profit, and cash flow totals are incorporated by reference from the Annual Report to Stockholders (Exhibit 13) and are not explicitly stated in the provided text. The following metrics are available from the filing text:
- Research, Development, and Engineering (R, D & E) Expenses: $25,630,000 (22% of revenue).
- Backlog: $25,992,000 as of December 31, 2002.
- Allowance for Doubtful Accounts: Ended the year at $2,207,000.
- Reserve for Inventory Obsolescence: Ended the year at $20,478,000.
- Stock Outstanding: 46,921,916 shares as of February 23, 2003.
- Market Value of Voting Stock: $790,039,000 (as of June 28, 2002).
Material Changes vs. Prior Period
- Backlog Growth: Backlog increased significantly to $25,992,000 in 2002, compared to $15,984,000 in 2001.
- Customer Concentration: Reliance on top customers decreased. The top five customers accounted for 10% of revenue in 2002, down from 15% in 2001 and 29% in 2000.
- End-User Revenue: Revenue from end-user customers rose to approximately 67% in 2002, up from 56% in 2001.
- International Sales: Sales outside the U.S. represented approximately 60% of revenue in 2002, a slight decrease from 63% in 2001.
- Manufacturing Transition: Completed the transition of contract manufacturing for the majority of MVSD products from a Massachusetts vendor to a European vendor.
- Inventory Reserves: The reserve for inventory obsolescence grew substantially from $3,709,000 in 2001 to $19,563,000 at the beginning of 2002, reflecting significant charges in the prior year, and ended 2002 at $20,478,000.
Outlook, Risks, and Contingencies
Management Commentary & Strategy: The company continues to invest in R&D and acquisitions to expand its product line and global presence. Management emphasizes high value-added products and a shift toward the end-user market. The company maintains a strong direct sales force in North America, Japan, Europe, and Southeast Asia.
Key Risks:
- Economic Conditions: Revenue is heavily dependent on capital spending in the semiconductor and electronics industries, which are cyclical. Approximately 44% of 2002 revenue was derived from these sectors.
- Forecast Accuracy: The expansion into the end-user market, which operates with short backlogs, increases the risk of inventory obsolescence if demand forecasts are inaccurate.
- Supply Chain: The company relies on third-party contract manufacturers and single-source suppliers for certain components.
- Intellectual Property Litigation: The company is involved in ongoing litigation with the Lemelson Medical, Educational, & Research Foundation regarding patent infringement claims. A trial concluded in January 2003, with a decision expected before the end of 2003. The company disclaims liability for indemnification requests from customers regarding these claims.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures in the Annual Report to Stockholders (Exhibit 13), as these totals are not explicitly listed in the 10-K text provided.
- Monitor the outcome of the Lemelson patent litigation, as a negative ruling could impact future sales or result in significant legal costs.
- Assess the impact of the inventory obsolescence reserve ($20.5 million) on future margins and the company's ability to manage inventory levels in a cyclical market.
- Review the backlog composition to determine if the increase to $26 million represents firm orders or is subject to cancellation, given the short lead times for certain products.
- Confirm the status of single-source component suppliers to evaluate supply chain continuity risks.